Klarna receives regulatory approval to take on Monzo and Revolut July 30, 2025 Swedish fintech Klarna has received an electronic money institution licence from the Financial Conduct Authority, setting the firm up to compete with UK firms Monzo and Revolut. The licence will allow Klarna to offer its 11 million UK customers savings accounts and also pave the way for a debit card launch. Abby Vickers, Klarna’s head [...]
AIM turns 30: Delistings, doubt and a dose of optimism June 19, 2025 AIM turns 30 today, but birthday celebrations are bound to be overshadowed by swathes of bleak data on the market’s performance. London’s junior stock market has had a woeful period, with projections indicating the index will shrink by a fifth as a result of delisting plans. The number of companies listed on the City’s Alternative [...]
Legal & General: FTSE 100 giant touts asset management plans June 18, 2025 Legal & General is set to delve further into the asset management markets after outlining its fresh growth plan on Tuesday. The firm’s asset management arm, which oversees £1.1 trillion in assets, is setting out targets for the coming year to notch over £500m in operating profit. If successful, this would mark a sharp jump [...]
Paragon Bank shares jump after analysts hike target June 16, 2025 Shares in Paragon Banking Group jumped on Monday after analysts reiterated their ‘Buy’ rating. The FTSE 250 bank’s stock climbed over two per cent in afternoon trading, reaching 908.50p. This came after Peel Hunt analysts upped their target price on the lender to 1,030p from 950p. “The group’s capital and funding position remain strong, with [...]
UK fintech Wise ditches London primary listing for US June 5, 2025 Money transfer firm Wise dealt a crushing blow to the London Stock Exchange on Thursday, after announcing plans to transfer its primary listing to the US. The UK fintech’s new proposals include a dual listing in the UK and US, but with the latter as a primary base. Wise said transferring its main listing would [...]
GSK and Astrazeneca shares slump as Trump vows drug price cut May 12, 2025 GSK and Astrazeneca shares fall as Trump announces drug price cuts in a new executive order.
Standard Chartered shares downgraded after tariff bruising May 7, 2025 Analysts at UBS slapped a downgraded price on Standard Chartered’s shares after a bruising period for the lender amid geopolitical tensions. The analysts reduced the target share price to 1,215p from 1,310p but maintained their ‘Buy’ rating. Shares were down 0.6 per cent on Wednesday at 1,049p. In the fallout of President Donald Trump’s ‘Liberation [...]
Argentex shares crash as firm fights to survive May 6, 2025 Argentex shares plummeted nearly 90 per cent in early Tuesday deals as the firm resumed trading on London’s AIM. The embattled currency firm suspended its shares from trading on April 22 after it said its liquidity had significantly worsened as the US dollar weakened. The company then agreed to a takeover from rival IFX on [...]
Bank of America analysts slap ‘buy’ rating on Barclays shares May 1, 2025 Bank of America analysts gushed over Barclays’ first-quarter performance, reiterating their ‘buy’ rating on the stock. Analysts said that while geopolitical-related concerns ahead of results were understandable, the lender “printed a strong set of numbers”. The FTSE 100 bank booked a £2.7bn pre-tax profit, ahead of the £2.5bn pencilled in. This was boosted by income [...]
Study: Trading updates key for future performance April 15, 2025 Trading updates by UK-listed companies are key to predicting future share price movement, a new study has found. An analysis of 2,699 trading statements published over the last two years by research platform Stockopedia revealed that a five per cent jump on the day of a trading update is a leading indicator of share price [...]